EPI-001 is the first inhibitor of the androgen receptor amino-terminal domain. The single stereoisomer of EPI-001, ralaniten (EPI-002), is a first-in-class drug that the USAN council assigned a new stem class "-aniten" and the generic name "ralaniten".
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.